Krishna Institute Raises Stake in Arunodaya Hospitals

Krishna Institute of Medical Sciences (KIMS) recently expanded its stake in Arunodaya Hospitals, a subsidiary company, by acquiring an additional 3.00%. This increased investment brings KIMS’s total shareholding in the hospital chain to 70.66%. This move reflects KIMS’s commitment to bolstering its healthcare operations and strengthening its footprint in the competitive medical sector, ensuring broader control and the ability to offer enhanced services to a growing patient base.
KIMS’s Investment in Arunodaya Hospitals
In a strategic business move, Krishna Institute of Medical Sciences has increased its ownership in Arunodaya Hospitals by 3.00%. The increase brings KIMS’s total stake to 70.66%, reinforcing its position as a dominant force in the healthcare sector. This acquisition reflects the company’s strategy of expanding its hospital network and enhancing its service capabilities. By consolidating control over Arunodaya Hospitals, KIMS aims to improve operational efficiency, enhance the quality of healthcare services, and explore new growth avenues within the healthcare industry.
Krishna Institute of Medical Sciences (KIMS): Overview
Founded in 2005, Krishna Institute of Medical Sciences (KIMS) is a leading healthcare and educational institution based in Karad, Maharashtra. Known for its quality medical education and research programs, KIMS also operates Krishna Hospital and Medical Research Centre (KH&MRC), a well-respected healthcare facility accredited by NABH. The university offers undergraduate, postgraduate, and doctoral courses in various medical disciplines, providing comprehensive education and healthcare services.
KIMS Share Performance
As of December 06, 2024, 3:03 PM, shares of KIMS are trading at ₹612.20 per share with a decline of 0.55% from its previous day’s closing price. Over the last month, the stock has seen a rise of 9.50%.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.
Published on: Dec 6, 2024, 4:35 PM IST
We're Live on WhatsApp! Join our channel for market insights & updates
- CCI Clears Creation of JV Company Between Mercuria Energy Netherlands and Tata International Singapore
- Jindal India Completes ₹1,500 Crore Expansion Project in West Bengal with New Coating Facility
- Consumer Goods Makers Including Hindustan Unilever and Dabur Expect Volume Led Growth as Inflation Eases
- Zensar Technologies Final Dividend Record Date on July 11: What It Means for Shareholders?
- UltraTech Cement Eyes Acquisition of HeidelbergCement India



